Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Inks Consumables, Software Deals With PreOmics, Genedata

NEW YORK (GenomeWeb) – Bruker said on Friday that it has inked a pair of agreements related to new consumables and software for its 4D Proteomics technology.

Bruker and PreOmics said they signed a codevelopment and comarketing agreement that will focus on PreOmics iST sample prep technology on Bruker's TimsTOF Pro. The sample prep technology, called inStageTip (iST), removes detergents, polymers, salts, lipids, and other contaminants and has exceptional peptide recovery, Bruker said. New iST protocols enable robust and reproducible sample preparation with a significant time advantage compared to common protocols, and are suitable for integration in semi-automated, high-throughput sample prep.

In addition, Bruker and Genedata announced a partnership for the Genedata Expressionist software platform, which now supports Bruker's TimsTOF Pro 4D omics format. Native support of the latest TimsTOF Pro data file format opens new opportunities for streamlining and automating complex proteomics, metabolomics, and biotherapeutics characterization studies, Bruker said. The combined technologies enable the implementation of a next-generation host cell protein analysis platform, the company added.

Bruker is announcing the partnerships, as well as several new mass spectrometry products, at the American Society for Mass Spectrometry Conference, held June 2-6 in Atlanta.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more